Get Free Shipping on orders over $79
Non-Myeloablative Allogeneic Transplantation : Cancer Treatment and Research - Asad Bashey

Non-Myeloablative Allogeneic Transplantation

By: Asad Bashey (Editor), Edward D. Ball (Editor)

Paperback | 30 October 2012

At a Glance

Paperback


$169.00

or 4 interest-free payments of $42.25 with

 or 

Ships in 5 to 7 business days

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

More in Oncology

This Might Surprise You : A Breast Cancer Story - Hayley Gullen

RRP $32.99

$26.99

18%
OFF
What Does it Feel Like? - Sophie Kinsella

RRP $29.99

$24.99

17%
OFF
Principles and Practice of Gynecologic Oncology - Andrew Berchuck

RRP $511.90

$435.12

15%
OFF
Tumor Vascularization - Kathryne Darwin

$461.75

Solid Tumor Oncology - Lajuana Kelleher

$444.75

Handbook of Targeted Cancer Therapy - Jessica Conrad
LYMPH & LONGEVITY : The Untapped Secret to Health - Gerald M. Lemole

RRP $32.99

$25.75

22%
OFF